Clinical Trial Update: Botox on Vulvar Vestibulitis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Botox for vulvar vestibulitis is listed, with sponsor Rigshospitalet (Denmark); current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Diseases
• Vulvar Vestibulitis

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Vulvar Vestibulitis, Vulvar Diseases | Phase 4 | Status: UNKNOWN